Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting

被引：1
|
作者：
Li, Dandan [1 ]
Silvester, Jocelyn Anne [2 ]
Crowley, Matthew J. [3 ]
Yang, Jeff Y. [4 ]
Alexopoulos, Anastasia-Stefania [3 ]
Xu, Yang [5 ]
Zhan, Siyan [5 ]
Wang, Tiansheng [4 ]
机构：
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China
[2] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Harvard Celiac Dis Res Program, Boston, MA USA
[3] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[4] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, 2101 McGavran Greenberg Hall,Campus Box 7453, Chapel Hill, NC 27515 USA
[5] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
来源：
THERAPEUTIC ADVANCES IN CHRONIC DISEASE | 2020年 / 11卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1177/2040622320904301
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
    Wang, Tiansheng
    Lu, Wenchao
    Li, Dandan
    Tang, Huilin
    Yang, Jeff Y.
    Buse, John B.
    Sturmer, Til
    [J]. DIABETES CARE, 2019, 42 (06) : E89 - E91
  • [2] Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
    Ohyama, Katsuhiro
    Shindo, Junichiro
    Takahashi, Tomohiro
    Takeuchi, Hironori
    Hori, Yusuke
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
    Jing Huang
    Yuntao Jia
    Shusen Sun
    Long Meng
    [J]. BMC Pharmacology and Toxicology, 21
  • [4] Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
    Huang, Jing
    Jia, Yuntao
    Sun, Shusen
    Meng, Long
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [5] Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system
    Wenchao Lu
    Shusen Sun
    Jingkai Wei
    Sydney Thai
    Dandan Li
    Huilin Tang
    Tiansheng Wang
    Lulu Sun
    [J]. International Journal of Clinical Pharmacy, 2020, 42 : 1364 - 1368
  • [6] No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19
    Zhou, Jiang-Hua
    Wu, Bin
    Wang, Wen-Xin
    Lei, Fang
    Cheng, Xu
    Qin, Juan-Juan
    Cai, Jing-Jing
    Zhang, Xiao-Jing
    Zhou, Feng
    Liu, Ye-Mao
    Li, Hao-Miao
    Zhu, Li-Hua
    She, Zhi-Gang
    Zhang, Xin
    Yang, Juan
    Li, Hong-Liang
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (22) : 5576 - 5588
  • [7] Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system
    Lu, Wenchao
    Sun, Shusen
    Wei, Jingkai
    Thai, Sydney
    Li, Dandan
    Tang, Huilin
    Wang, Tiansheng
    Sun, Lulu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (05) : 1364 - 1368
  • [8] No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19
    Jiang-Hua Zhou
    Bin Wu
    Wen-Xin Wang
    Fang Lei
    Xu Cheng
    Juan-Juan Qin
    Jing-Jing Cai
    Xiao-Jing Zhang
    Feng Zhou
    Ye-Mao Liu
    Hao-Miao Li
    Li-Hua Zhu
    Zhi-Gang She
    Xin Zhang
    Juan Yang
    Hong-Liang Li
    [J]. World Journal of Clinical Cases, 2020, (22) : 5576 - 5588
  • [9] Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
    Raschi, E.
    Poluzzi, E.
    Koci, A.
    Antonazzo, I. C.
    Marchesini, G.
    De Ponti, F.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (05) : 380 - 386
  • [10] Safety Signals for Major Adverse Cardiovascular Events as a Composite Outcome with Dipeptidyl Peptidase-4 Inhibitors in the FDA Adverse Event Reporting System
    Baksh, Sheriza
    DeMarco, Mara McAdams
    Segal, Jodi
    Alexander, G. Caleb
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 183 - 183
12345